We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Par Pharmaceutical said yesterday the FDA has approved its NDA for Vasostrict injection, making it the first product of its kind to win approval. Read More
A key Senate health panel will consider a bipartisan bill to hasten the development of Ebola drugs by including the disease under a lucrative voucher program. Read More
The European Medicines Agency has released an online tool designed to help manufacturers report and edit information on their marketed products, as required under the 2010 pharmacovigilance law. Read More
The Scottish Medicines Consortium has approved five new medicines for reimbursement in Scotland, including treatments for cancer, hepatitis C and diabetes. Read More
European regulators say they are prepared to start a continual assessment of data on experimental Ebola treatments as soon as they receive each submission, in an effort to speed approvals. Read More
Researchers approaching the FDA with new drug development tools, such as potential biomarkers or innovative trial designs, will now have a centralized place to bring their ideas for advice as the agency replaces its fragmented approach to considering such concepts with a new streamlined system. Read More